Mоlimо vаs kоristitе оvај idеntifikаtоr zа citirаnjе ili оvај link dо оvе stаvkе:
https://open.uns.ac.rs/handle/123456789/32518
Nаziv: | β1-blockade increases maximal apnea duration in elite breath-hold divers | Аutоri: | Ryan Hoiland Philip Ainslie Anthony Bain David MacLeod Mike Stembridge Ivan Drviš Dennis Madden Otto Barak Douglas MacLeod Željko Dujić |
Ključnе rеči: | Adrenergic beta-1 Receptor Antagonists;divers;apnea;Blood Pressure;Breath Holding;Oxygen Consumption;Oxyhemoglobins;Propanolamines;Stroke Volume | Dаtum izdаvаnjа: | 2017 | Čаsоpis: | Journal of Applied Physiology | Sažetak: | We hypothesized that the cardioselective β1-adrenoreceptor antagonist esmolol would improve maximal apnea duration in elite breath-hold divers. In elite national-level divers (n = 9), maximal apneas were performed in a randomized and counterbalanced order while receiving either iv esmolol (150 μg.kg-1.min-1) or volume-matched saline (placebo). During apnea, heart rate (ECG), beat-by-beat blood pressure, stroke volume (SV), cardiac output (CO), and total peripheral resistance (TPR) were measured (finger photoplethysmography). Myocardial oxygen consumption (MVO2) was estimated from rate pressure product. Cerebral blood flow through the internal carotid (ICA) and vertebral arteries (VA) was assessed using Duplex ultrasound. Apnea duration improved in the esmolol trial when compared with placebo (356 ± 57 vs. 323 ±61 s, P < 0.01) despite similar end-apnea peripheral oxyhemoglobin saturation (71.8 ± 10.3 vs. 74.9 ± 9.5%, P = 0.10). The HR response to apnea was reduced by esmolol at 10-30% of apnea duration, whereas MAP was unaffected. Esmolol reduced SV (main effect, P < 0.05) and CO (main effect; P < 0.05) and increased TPR (main effect, P < 0.05) throughout apnea. Esmolol also reduced MVO2 throughout apnea (main effect, P < 0.05). Cerebral blood flow through the ICA and VA was unchanged by esmolol at baseline and the last 30 s of apnea; however, global cerebral blood flow was reduced in the esmolol trial at end-apnea (P < 0.05). Our findings demonstrate that, in elite breath-hold divers, apnea breakpoint is improved by β1-blockade, likely owing to an improved total body oxygen sparring through increased centralization of blood volume (∵ TPR) and reduced MVO2. | URI: | https://open.uns.ac.rs/handle/123456789/32518 | ISSN: | 8750-7587 | DOI: | 10.1152/japplphysiol.00127.2016 |
Nаlаzi sе u kоlеkciјаmа: | MDF Publikacije/Publications |
Prikаzаti cеlоkupаn zаpis stаvki
Prеglеd/i stаnicа
26
Prоtеklа nеdеljа
4
4
Prоtеkli mеsеc
4
4
prоvеrеnо 15.03.2024.
Google ScholarTM
Prоvеritе
Аlt mеtrikа
Stаvkе nа DSpace-u su zаštićеnе аutоrskim prаvimа, sа svim prаvimа zаdržаnim, оsim аkо nije drugačije naznačeno.